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Abstract
Background: Stem cells constitute a group of great capacity for self-renewal, long-term viability, and multi-lineage
potential. Several studies have provided evidence that adipose tissue represents an alternative source of stem cells,
with the main benefit of adipose-derived stem cells being that they can be easily harvested from patients by a
simple minimally invasive method and can be easily cultured. The aim of this study was to establish a culture
protocol for obtaining and characterizing adipose-derived stem cells (ADSCs) from C57BL/6 J mice.
Results: The results showed that the yield, viability, and cell morphology obtained differ according to the age of
isolated anatomic regions of the adipose tissue from ovarian and epididymis. The results of determination of cyclin
D1 showed uniformity in the expression between different populations of ADSCs. A significant increase in the
expression of caspase-3 active, was also observed in large cell populations from mice after 120 days. ADSCs were
positive for mesenchymal markers CD90 and CD105, Nanog, SSEA-1, CD106, and VEGFR-1, and negative for
hematopoietic markers CD34 and CD45. A large number of cells in S + G2/M phases was also observed for both
sexes, demonstrating high proliferative capacity of ADSCs.
Conclusions: We observed that the adipose tissue of C57BL/6 J mice, isolated from the studied anatomic regions,
is a promising source for obtaining pluripotent mesenchymal stem cells with high viability and proliferative
response.
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Background
Stem cells constitute a group of great capacity for self-
renewal, long-term viability, and multilineage potential
[1]. The multilineage potential of embryonic and adult
stem cells from bone marrow has been characterized ex-
tensively. In spite of the potential of embryonic stem cells
for medical applications, many ethical and political issues
accompany their use [2,3]. Stem cells therapy and ex vivo
gene delivery have provided two promising strategies for
treatment of a vast array of inherited and acquired disor-
ders. For these types of therapy, a reliable source of stem
cells appears necessary. Researchers mainly work on two
types of stem cells, embryonic and adult stem cells.
However, immunorejection, tumorigenicity and ethical
opposition have impeded the advancement of embryonic
stem cells for clinical applications [4]. Compared with em-
bryonic stem cells, autologous adult stem cells do not
raise any major ethical or immunologic problems. Sources
of adult stem cells include muscle, bone marrow, blood,
epidermis, brain, liver, and, more recently, adipose tissue
[3]. Stem cells derived from bone marrow were able to re-
place damaged heart muscle in mice after myocardial in-
farction [5].
However, the relatively low incident small tissue volume,
difficult access, and disease-related malfunction of bone
marrow-derived stem cells hamper their clinical useful-
ness. Several studies have provided evidence that adipose
tissue represents an alternative source of stem cells and is
routinely available in large quantities from low-risk tech-
niques through non-invasive liposuction. Deposits of sub-
cutaneous adipose tissue are an affordable, abundant, and
highly capable replacement, thus providing a potential
reservoir of adult stem cells in each individual. Many
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research groups, working independently, have demon-
strated that adipose-derived stem cells (ADSCs) are able to
differentiate in vitro into multiple lineages, among them ad-
ipocytes, chondrocytes, hepatocytes, osteoblasts, and endo-
thelial, epithelial, hematopoietic, neuronal and myogenic
cells [6]. Adipocytes derived from pluripotent cells that
become precursors to mesenchymal are capable to turn
into chondroblasts, osteoblasts, myoblasts or preadipocytes
closely with vascular cells, stroma and extracellular matrix
and are influenced by transcription factors and exogenous
hormones. The components of extracellular matrix modu-
late the differentiation of preadipocytes and produce adhe-
sive molecules which provide intercellular bonds and
changes in morphology and size of adipocytes [7].
The main benefit of ADSCs is that they can be easily
harvested from patients by a simple, minimally invasive
method, and they can be easily cultured. Moreover,
adipose-derived stromal/stem cells can be propagated
more rapidly, and they retain their mesenchymal pluri-
potency, such as, 2.3 × 108 cells to 120 mL, 80% conflu-
ent on the third pass [8]. Some investigations have
indicated that ADSCs possess different surface epitopes
and differentiation potential according to the localization
of the fat pad from which the cells were derived. Epicar-
dial adipose-derived cells tend to have a short popula-
tion doubling time (45 ± 9.6 hours) than the epididymis
adipose-derived stem cells (69 ± 16 hours). There are dif-
ferences among deposits of ADSCs in different anatomic
sites regarding their proliferative capacity and aging
in vitro [9]. ADSCs from ovarian and epididymis have
not yet been characterized. Therefore, the aim of this
study was to establish a protocol for obtaining and
characterization of ADCSs from male and female mice
at different ages.
Results
Isolation and culture
The samples of adipose tissue from ovarian and epididymis
of different experimental groups were digested and cul-
tured. During the initial days after plating, stem cells iso-
lated from adipose tissue adhered to the surface of the
culture plastic plates as a small cell population or polygonal
spindle shaped forming a cells monolayer. The ADSCs
proliferated rapidly in vitro, forming a homogeneous com-
position in monolayer, with fibroblast-like morphology
(Figure 1). No difference was observed in fibroblast-like
morphology presentation between large and small adipo-
cyte obtained. The yield, morphology, and viability of cells
obtained differed according to the age of tissue isolated
from mice.
Male mice 30 days showed an average of 1.2 ± 0.2 × 105
cells in 0.21 g of tissue while in the group of female mice
of same age, the average obtained was 1.5 ± 0.9 × 105
in 0.24 g of tissue. In male mice 90 days, the average was
1.6 ± 1.1 × 105 cells in 0.27 g of tissue while females of
same age had a mean of 1.4 ± 0.6 × 105 cells in 0.41 g of
tissue. At 120 days, there was a significant increase in yield
of adipose tissue in relation to the total mass. In males
28.1 × 105 ± 6.3 in 0.34 g of tissue was obtained and in fe-
males 34.3 ± 15.2 × 105 cells in 0.26 g of tissue was ob-
tained (Figure 2).
Morphological characterization
The different populations of ADSCs were characterized by
flow cytometry, as small or large, according to distinct
morphological characteristics.
In males of 30 days 37.8% ± 2.5 of small cells was ob-
tained and 62.9% ± 7.9 of large cells, in 90 days 32.2% ± 2.5
of small cells and 69.5% ± 8.5 of large cells and in 120 days
43.4% ± 9.7 of small cells and 56.4% ± 8.7 of large cells. On
the other hand, in females of 30 days, 31.9% ± 8.2 was ob-
tained and 66.0% ± 6.0 of small and large cells respectively,
in 90 days 42.5% ± 10.8 of small cells and 54.7 ± 12.8% of
large cells, and finally in 120 days, 21.2% ± 6.1% of small
cells and 77.3% ± 12.2 large cells (Figure 2).
Expression of stem cells markers on adipose cell
populations by flow cytometry
The expression of CD105, CD45, CD90, CD34, CD106,
VEGFR-1, Nanog, and SSEA-1 was analyzed by flow cy-
tometry. The results for males of 30 days were 52.2 ±
7.0%, 19.3 ± 2.6%, 56.8 ± 2.0%, 5.4 ± 4.4%, 75.7 ± 8.9%,
83,4 ± 10.7%, 62.0 ± 12.4% and 24.9 ± 3.9% respectively, for
males of 90 days were 54.4 ± 3.0%, 24.5 ± 2.8%, 56.2 ±
4.7%, 6.2 ± 3.2%, 81.5 ± 12.1%, 83.9 ± 14.5% and 34.8 ±
8.7% respectively. The expression of SSEA-1 in 90 days is
not represented in graphs, because there was no notice-
able difference compared to the previous period in both
sexes. For males in 120 days were 59.9 ± 14.9%, 9.4 ± 1.0%,
75.8 ± 3.7%, 12.7 ± 2.5%, 75.7 ± 5.9%, 79.3 ± 18.2%, 34.0 ±
9.1% and 12.7 ± 2.5%, respectively (Figures 3A and 4). In
females, the expression in the group of 30 days was 56.2 ±
6.3%, 5.6 ± 0.9%, 49.7 ± 10.6%, 11.3 ± 1.5%, 80.4 ± 13.1%,
39.5 ± 10.1%, 77.0 ± 10.9% and 26.6 ± 4.2%. For the group
of 90 days was 55.3 ± 1.2%, 16.2 ± 1.6%, 51.5 ± 4.2%, 9.7 ±
1.7%, 79.3 ± 10.9%, 52.1 ± 17.7% and 83.4 ± 17.8%, and fe-
males of 120 days, 65.1 ± 5.6%, 8.8 ± 0.5%, 61.1 ± 4.2%,
10.5 ± 2,1%, 84.3 ± 17.7%, 51.1 ± 12.7%,42.5 ± 9.7% and
14.7 ± 2.9%, respectively. The difference among the posi-
tivity for expression of mesenchymal and hematopoietic
markers was significant (**p < 0.001) (Figures 3B and 4).
Expression of cyclin D1 and caspase-3 active by flow
cytometry
The results of expression of cyclin D1 showed homogen-
eity increased among different populations of ADSCs and
between small and large cells from males and females. Ex-
pression of cyclin D1 in males of 30 days was 85.0% for
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Figure 1 Adipose-derived stem cells from C57BL/6 mice observed under inverted microscopy after culture. For this study, were utilized
10 animals for sex, and experimental period of 30, 90, and 120 days (total of animals = 60). A and B: Initial explant of ADSCs (magnification, ×40
and × 20). It was observed in the cultures of adipose tissue, cells fusiform with appearance of fibroblast-like (arrowhead) and small cells adipose
refractive rounded (arrow). C and D: Culture of ADSCs after 7 days (magnification, ×10 and × 20). E and F: Culture of ADSCs after 10 days. It is
possible to observe cell confluence and homogenous population (magnification, ×5 and × 40). G and H: Culture of ADSCs above three passages
on tissue culture plastic (magnification, ×20). Cell confluence was observed and homogenous population with small and lager cells in this period.
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small cells and 84.2% for large cells; for the group of
90 days, it was 82.2% and 89.9% for small and large cells,
respectively; and in the group of 120 days it was 83.5% for
small cells and 86.4% for large cells. On the other hand, in
females of 30 days, 82.3% and 83.7% was obtained for
small cells and large cells, respectively, for the group of
90 days it was 82.9% for small cells and 84.9% for large
cells, and finally for the group of 120 days, 81.2% of small
cells and 87.3% of large cells (Figure 5).
Expression of caspase-3 active for males of 30 days
was 17.4% for small cells and 17.3% for large cells, for
the group of 90 days, 13.5% for small cells and 18.7% for
large cells, and for the group of 120 days, 15.7% and
31.7% for small cells and large cells, respectively. In fe-
males of 30 days, the expression was 15.8% for small
cells and 12.9% for large cells, in 90 days it was 14.1%
for small cells and 15.8% for large cells, and finally, in
120 days it was 14.7% for small cells and 28.5% for large
cells (Figure 6).
Cell cycle phases distribution
At 30 days, accumulated cells in G0/G1 phase were ob-
served, in which a large number of cells were found, being
68.3% for males and 72.4% to females. At 120 days, there
was a decrease of cells in this phase, being 51.3% for males
and 57.1% for females. In the synthesis phase, there was
an increased number of cells. Regarding S/G2/M phases,
there was a higher cell concentration for males at 30 days,
with 47.5% and for females 27.6%. At 120 days the results
for the same phases were inversely proportional for both
sexes, compared to the previous period. While in the sub-
haploid population in 30 days, there was a similar propor-
tion for both sexes, with 9.2% for males and 8.5% for
females. However, in 120 days there was an increase in the
number of cells in the sub-haploid (Figure 7).
Discussion
Research shows that human adipose tissue obtained from
liposuction is an abundant and an available source of
ADSCs and can be used for research purposes. Stem cells
from adipose tissue were first isolated from collected frag-
ments of rodent adipose tissue through open surgery.
Later, several groups have reported the isolation of human
ADSCs taking advantage of liposuction aspirate as a tissue
source [9]. The ADSCs cells display a reproducible and
consistent phenotype based on cell-yield viability, adipo-
cyte differentiation, and cell-surface marker phenotype. In
this work, the use of mechanical and enzymatic tech-
niques to isolate ADSCs from mice, proven to be effective
once an adherent single cells layer were obtained, acquired
a fibroblast-like morphology, this being one characteristic
of mesenchymal stem cells. The characterizations of
Figure 2 Cell populations and weight of tissue (g) of ADSCs from C57BL/6 J mice males and females. For this study were utilized 10
animals for sex, and experimental period of 30, 90 and 120 days (total of animals = 60). Results represent means ± S.D. from three independent
experiments of each experimental group (days and sexes) in triplicate. A: The graph shows the cell yield acquired of ADSCs from C57BL/6 J mice
males and females among 30, 90, and 120 days of age, subdivided into morphological group of small or large, after characterization by flow
cytometry. Tissue weight (#). Statistical differences were obtained by analysis of variance ANOVA and Tukey-Kramer multiple-comparisons test. No
significant difference was seen in the groups. B (Male 30 days) and C (Female 30 days): The scatter plot of FSC vs. SSC shows the subdivided into
morphological group of small or large, after characterization by flow cytometry.
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Figure 3 Analysis of stem cell markers expression of ADSCs from C57BL/6 J mice males and females. Results represent means ± S.D. from
three independent experiments of each experimental group (days and sexes) in triplicate, obtained by flow cytometry analysis. The percentages
of ADSCs mice males (A) and females (B) among 30, 90, and 120 days of age expressing hematopoietic stem cell markers (CD45 and 34),
mesenchymal (CD90 and CD105), Nanog, CD106, and VEGFR-1 were correlated with the age and sex of animals. The difference between the
positivity for expression of mesenchymal and hematopoietic markers was statistically significant. Statistical differences were obtained by analysis
of variance ANOVA and Tukey-Kramer multiple-comparisons test. Statistical significance (p-value) *p < 0.05, **p < 0.01 and ***p < 0.001.
Figure 4 Analysis of SSEA-1 expression of ADSCs from C57BL/6 J mice males and females. Results represent means ± S.D. from three
independent experiments of each experimental group (days and sexes) in triplicate, obtained by flow cytometry analysis. A: The graph shows
ADSCs from mice males and females between 30 and 120 days of age characterized by flow cytometry compared with SSEA-1 expression. B, C,
D, and E: A single fluorescent dye was used for a dot plot vs. FSC to visualize the expression of the markers of SSEA-1. B: SSEA-1 expression at
female 30 days; C: SSEA-1 expression at female 120 days; D: SSEA-1 expression at male 30 days; E: SSEA-1 expression of male 120 days. Statistical
differences were obtained by analysis of variance ANOVA and Tukey-Kramer multiple-comparisons test. Statistical significance (p-value) *p < 0.05
and **p < 0.01.
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fibroblast-like morphology have been used as criteria in
assessing the potential difference of stem cells of mesen-
chymal origin [10,11].
In this study, during the first days after culture, ADSCs
adhered to the flask surface, as a small or fusiform popula-
tion of polygonal cells. The ADSCs expand easily in vitro
and exhibited a homogeneous fibroblast-like morphology.
The cells were sub-cultured within 1–2 days, when cells
became 90% confluent.
The yield of ADSCs was expressive with an average of
87.0%, and cell viability greater than 94.0%. The data
showed that the number of ADSCs and viability ac-
quired from mice at different ages was greater than that
obtained in recent studies. These studies showed that
Figure 5 Analysis of cyclin D1 expression of ADSCs from C57BL/6 J mice males and females. Results represent means ± S.D. from three
independent experiments of each experimental group (days and sexes) in triplicate, obtained by flow cytometry analysis. The graph shows ADSCs
from mice males and females among 30, 90, and 120 days of age subdivided into morphologically large and small cells after characterization by
flow cytometry compared with cyclin D1 expression. Statistical differences were obtained by analysis of variance ANOVA and Tukey-Kramer
multiple-comparisons test. No significant (ns) difference at the groups.
Figure 6 Analysis of caspase-3 active expression from ADSCs from C57BL/6 J mice males and females. Results represent means ± S.D.
from three independent experiments of each experimental group (days and sexes) in triplicate, obtained by flow cytometry analysis. The graph
shows ADSCs from mice males and females among 30, 90, and 120 days of age subdivided into morphologically large and small cells after
characterization by flow cytometry compared with caspase-3 active expression. Statistical differences were obtained by analysis of variance
ANOVA and Tukey-Kramer multiple-comparisons test. Statistical significance (p-value) *p < 0.05.
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1 g of adipose tissue can yield approximately 4-5×106
cells, including 1×106 adipocytes, 1×106 ADSCs, 1×106
vascular endothelial cells, and 1x106 other cells. [12,13].
Our group obtained recently stem cells of synovial mem-
brane from equines and the data corroborate in ADSCs
yield (data not shown). When comparing the results
with the number of cells that can be obtained from hu-
man adipose tissue, acquired by liposuction, there were
higher mean values in this study. About 2.0% of human
lipoaspirate are ADSCs, or in 10 g of adipose tissue,
about 0.2 g of mesenchymal stem cells could be isolated
and used to perform cell therapy because these cells
possess a large capacity to expand in culture, even ac-
counting for a small fraction of adipose tissue [14]. The
isolation of adipose tissue from infundibulum of ovarian,
epididymis, and proximal regions showed significant cell
yield compared to other studies [15-17] and satisfactory
viability when compared with results obtained in humans,
which was about 93.9 ± 3.3% based on test trypan blue ex-
clusion [15].
The weight of tissue and amount of isolated cells dif-
fered according to the age and sex of animals. It was ob-
served that females 90 days showed higher accumulation
of adipose tissue in studied regions compared with males
of the same age, however, at 30 and 120 days, the males
showed a higher amount of adipose tissue than females.
Comparing the cell yield with sex and age of animals, it
was observed that there was a significant increase in
Figure 7 Analysis of cell cycle phases of ADSCs from males and females. Results represent means ± S.D. from three independent
experiments of each experimental group (days and sexes) in triplicate, obtained by flow cytometry analysis. A: The proportion of ADSCs from
C57BL/6 J females and males 30 days residing in sub-haploid, G0/G1, S and G2/M are indicated; B: The proportion of ADSCs from C57BL/6 J
females and males with 120 days in sub-haploid phase, G0/G1, S and G2/M was indicated. Statistical differences were obtained by analysis of
variance ANOVA and Tukey-Kramer multiple-comparisons test. Statistical significance (p-value) *p < 0.05. C, D, E, and F: Cell cycle analysis of flow
cytometric DNA histograms. C: Histogram shows the proportion of ADSCs from C57BL/6 J females 30 days in sub-haploid phase, G0/G1, S and
G2/M cell cycle phases; D: Histogram shows the proportion of ADSCs from C57BL/6 J males 30 days in sub-haploid phase, G0/G1, S and G2/M cell
cycle phases; E: Histogram shows the proportion of ADSCs from C57BL/6 J females 120 days in sub-haploid phase, G0/G1, S and G2/M cell cycle
phases; F: Histogram shows the proportion of ADSCs from C57BL/6 J males 120 days in sub-haploid phase, G0/G1, and G2/M cell cycle phases.
The histograms were obtained by ModFit 3.2 software.
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relation to age, represented mainly by large cell popula-
tions. However, there was no relation among the weight of
adipose tissue, the amount of cells obtained, cell morph-
ology, and age of animals.
The amount and anatomical region of stored fat differs
in females and males. Females tend to have a higher body
fat content, localized subcutaneously, while males have
less total body fat and their adipose tissue predominates in
the visceral region. Estrogen is a major factor involved in
this sexual dimorphism as it promotes subcutaneous fat
accumulation, has anti-inflammatory properties, and is a
strong regulator of appetite and energy expenditure [18].
Estrogen regulates the amount of white adipose tissue
(WAT) in females, but its role in males and whether
WAT effects involve expression of estrogen receptor-
alpha (ER-α) or receptor-beta (ER-β) were as yet unclear
[19,20].
Mesenchymal stem cells (MSCs) have no expression for
hematopoietic surface markers CD34, CD45, and CD14
and endothelial cells CD31, and are positive for STRO-1,
CD29, CD73, CD90, CD105, CD166, and CD44 [21]. The
data obtained in this study showed that the cells studied
exhibit significant expression of mesenchymal markers
CD90 and CD105, corroborating other results [22], and
low expression of hematopoietic markers CD34 and
CD45. Thus, the results suggest that mesenchymal stem
cells were isolated from adipose tissue of mice.
The expression of CD105 and CD34 increased signifi-
cantly with enhanced VEGF expression [23]. Expression of
markers CD9, CD29, CD44, CD49d, and CD106 interfere
with the proliferation and differentiation of hematopoietic
stem cells. Preliminary studies indicated that adipose
tissue-derived stromal cells are capable of supporting
hematopoiesis in vitro [24].
The markers did not differ in relation to the sex of an-
imals. However, there was a higher positivity of markers
in large-cell populations, as well as the findings of other
authors [25], who observed that large cells showed
higher expression of markers of mesenchymal cells. It
was observed that at mice 120 days there was a decrease
in the expression of markers of mesenchymal cells in
both sexes and a not very significant increase in expres-
sion of hematopoietic markers. The increase of these
markers may be explained at this age for a period of
maturation of ADSCs, causing the greatest potential for
hematopoietic cells.
According to reports in the literature about stem cells
derived from stromal vascular fraction (SVF) of adipose
tissue, up to three passage, has distinct populations of cells
divided into small and large stem cells, supporting results
obtained from ovarian and epididymis. Following adher-
ence of the SVF to tissue culture flasks (MSCs, passage 1)
the immunophenotype became more homogenous for
both the large and small cells [25]. In literature, 53.0% of
mesenchymal large cells exhibit 79.0% viability; whereas
47.0% of small cells have 94.0% viability, thus, the size of
mesenchymal cells interferes with cell viability [25]. In our
study, were observed the existence a significant increase
in the expression of caspase-3 active at 120 days, in large
cells populations, demonstrating that during this period
the activation of apoptosis occurs, which may be a balance
mechanism of the cell number when they reach maximum
potential of maturation. Regarding the expression of cyclin
D1, no significant difference was seen among markings in
populations of ADSCs and between sexes.
Researchers described that the age is a limiting factor
for the use of adult stem cells due to accumulation of in-
trinsic events, such as DNA mutations, as well as the
extrinsic (changes in the stem cell niche). It is assumed
that, with advancing age, the mechanism responsible for
suppression of development of tumors, such as senescence
and apoptosis, may induce a decline of multiplicative
function of stem cells [26]. Various intrinsic programs and
pathways facilitate the unique characteristics of stem cells,
and these programs, in charge of everything maintenance,
to proliferation, to eventual differentiation of the stem
cells, have to be tightly controlled by the microenviron-
ment [27].
In early G1-phase, cyclin-D family comes together in a
holoenzyme complex with one or two catalytic subunits
of cyclin-dependent kinases (CDKS), Cdk4 e Cdk6 [28].
Analysis of cell cycle phases that the age represents, for
both sexes, showed that the major cell populations are
in G0/G1, corroborating the expression of the cyclin-D1.
However, in 120 days there was a decrease in the phases
G0/G1 for both sexes. A large number of cells were
observed in phases S + G2/M, for both sexes, demon-
strating high proliferative capacity of the ADSCs, as we
discussed previously. However, in 120 days an increase
of cell number was observed in phase sub-haploid for
both sexes. This increase demonstrates the loss of cell
viability, also evidenced by the significant increase of the
caspase-3 in the same period. Most cells with sub-
haploid DNA content correspond to apoptotic cells with
fragmented DNA or condensed chromatin [29]. This
process may result in the presence of cellular debris and
nucleus containing small amounts of DNA [30]. Then,
the fraction sub-haploid quantified in flow cytometry
may contain, in addition to apoptotic cells, cellular and
nuclear fragments, nucleus or micronucleus with normal
content of DNA, but containing a different chromatin
structure [31].
In early embryonic development, cell fate is regulated by
the core transcription factor network, which includes
octamer-binding transcription factor 4 (Oct-4), sex deter-
mining region Y-box2 (Sox-2), homeobox protein Nanog,
signal transducer and activator of transcription 3 (Stat-3),
and some other factors [32]. Nanog is the first transcription
Luna et al. BMC Research Notes 2014, 7:552 Page 8 of 12
http://www.biomedcentral.com/1756-0500/7/552
factor that is restricted to the inner cell mass after compres-
sion [33]. Nanog represses embryonic ectoderm differenti-
ation but has little effect on other lineages, whereas Sox-2
and Sox-3 are redundant and repress mesendoderm differ-
entiation [34]. Nanog has been detected only in proliferat-
ing cells, but not in MSCs induced to differentiate. The
percentage of cells expressing Nanog was maintained
throughout early passages of MSCs, but then started to de-
crease in late passages in MSCs from adipose tissue and
heart but not from bone marrow [35]. We found that
Nanog expression was positive for both sexes and ages. Ex-
pression of Nanog for females of 90 days increased signifi-
cantly compared with males of the same age. At the pre-
implantation stage, murine embryos, human germ cells,
and teratocarcinoma stem cells express certain molecular
receptors known as Stage Specific Embryonic Antigens
(SSEA) on their membrane surface [36]. SSEA-1 and
Nanog occur in embryonic stem cells; both have an import-
ant role in maintaining the capacity for self-renewal [37].
Thus these markers have been used to characterize mouse
and human embryonic stem cells [38]. The expression of
SSEA-1 in the cells supports the marking of Nanog, being
positive in both sexes and ages analyzed, but there was no
significant difference between sexes. Cell culture at 90 days
is not represented in the graphs because there was no no-
ticeable difference compared to the previous period. There
was a significant decrease in SSEA-1 expression for both
sexes. These results indicate that these cells are pluripotent
and the method for establishing them is feasible. The litera-
ture showed in histological and cytometric analyzes that
SSEA-1 was expressed at high levels in ADSCs. In ADSCs
cultured, at passage 0, it was expressed at a higher level
than CD34 [39]. Gender differences were found to affect
the osteogenic capacity of ADSCs, with ADSCs from males
differentiating more rapidly and more effectively than
ADSCs from females in vitro; the adipogenic potential was
unchanged irrespective of age, while the osteogenic poten-
tial appears to decrease with increasing age. These differ-
ences are likely due to the different steroid functions in
males and females with hormone levels ranging at different
phases of life [35].
Members of the VEGF family show different affinities
for one of three VEGF tyrosine kinase receptors: VEGF
R-1, R2, or R3 [40]. Studies targeting genes in mice have
shown the importance of VEGFs and VEGFRs in the de-
velopment of the vascular system [41]. Despite a high de-
gree of homology within the kinase domains, the signaling
properties of different VEGFs greatly differ. The fact that
VEGFR-1be is usually expressed at low levels has ham-
pered progress in elucidating its signal transduction path-
ways. VEGFR-1 has been shown to mediate monocyte
migration, recruitment of endothelial cell progenitors,
hematopoietic stem cell survival, and release of growth
factors from liver endothelial cells [42,43]. VEGFR-1 is a
positive regulator of monocyte and macrophage migra-
tion, and has been described as a positive and negative
regulator of VEGFR-2 signaling capacity. Moreover, the
migration of hematopoietic progenitor cells, as well as
monocytes, towards a gradient of VEGF is mediated
through VEGFR-1 [41]. The results of the determination
of VEGFR-1 showed uniformity in the expression between
30 and 120 days of age, however, receptor expression in
females is significantly decreased compared with males of
the same age. The high VEGFR-1 expression can be ex-
plained by the change in adipose tissue because it is one
of the most vascularized tissues of the body, and a close
functional relationship exists between fat tissue and its
vasculature.
Other studies have reported the involvement of VEGFR-1
signaling in fat tissue formation. For example, mice defi-
cient of placenta-derived growth factor (PlGF, specific lig-
and for VEGFR-1) have lower body weights during the later
stages of diet-induced obesity. However, pharmacologic in-
hibition of PlGF had no apparent effect and adipogenesis is
dependent on VEGF-mediated formation of new blood ves-
sels [44]. MSCs can also increase angiogenesis. Rats treated
with MSCs had significant increases in numbers of newly
formed capillaries at the boundary of the ischemic lesion in
rats treated with human MSCs. Decreased VEGFR-1 ex-
pression in females when compared to males may be re-
lated to the pregnancy period. In rats, mRNA for VEGF164
is increased during pregnancy (5.0 fold increase on 12th
day) and during lactation (18.5-fold increase on 7th day).
VEGF 120, 165 and 188 amino acid isoforms are expressed
during pregnancy, lactation, and involution, and their abun-
dance relative to one another does not alter during the
mammary gland cycle. In mice, there is an increase in
VEGF mRNA levels during the phase of lactation (maximal
9.7-fold at 7th day); levels of VEGF decreased progressively
during the phase of involution. In relation to VEGFR-1 and
VEGFR-2, a quantitative analysis in the rat mammary gland
revealed an increase in VEGFR-2 during pregnancy
(1.6- fold at 4th day). During lactation, VEGFR-1 (2.7-
fold at 7th day) and VEGFR-2 (3.8- fold at 7 th day) in-
creased [45].
The reproducibility and consistency of these primary hu-
man cells support their value as an adult stem cell model,
and may be used with great potential in basic research and
preclinical studies. Several studies have demonstrated the
potential of these stem cells. ADSCs were able to improve
peripheral nerve regeneration in vivo when compared with
no conduits cells [46]. The ability to isolate a consistently
homogeneous population of undifferentiated adult stem
cells from adipose tissue from studied anatomical regions,
supports their potential utility in future tissue-engineering
applications. Adipose tissue represents a precious source of
multipotent cells with a great potential for several clinical
applications, above all in the field of regenerative medicine
Luna et al. BMC Research Notes 2014, 7:552 Page 9 of 12
http://www.biomedcentral.com/1756-0500/7/552
[11]. ADSCs have the relative advantages of accessibility
and abundance. This means that there is less pain to the
patient in obtaining the cells and it is easy to obtain a suffi-
cient quantity of cells.
Conclusion
The use of mechanical and enzymatic techniques to iso-
late ADSCs of mice is proven to be an effective method,
once an adherent single cells layer was obtained. The
data showed that number of ADSCs, and viability, ac-
quired from adipose tissue of mice, at different ages and
different anatomical sites, is greater than that obtained
in recent studies. The high VEGFR-1 expression can be
explained by must be change the adipose tissue because
it is one of the most vascularized tissues of the body and
a close functional relationship exists between fat tissue
and its vasculature. The data obtained in this study
showed that cells studied exhibit significant expression
of mesenchymal markers CD90 and CD105 and pluripo-
tency markers Nanog, SSEA-1, as well as a marker of
proliferation potential Nanog. These results indicate
these cells are pluripotent and that the method for es-
tablishing them from ADSCs is feasible. The results sug-
gest that adipose tissue, isolated from the studied
regions is a promising alternative source of stem cells.
The yield and cell viability of the ADSCs acquired in
this study make these cells a potential source in tissue
engineering applications.
Methods
Animals
All experiments protocols were approved by ethics commit-
tee on animal use from Butantan Institute. For this study,
60 animals were used. Adipose tissue was collected from
normal mice C57BL/6 J, males and females of 10 mice/
group (aged 4 to 16 weeks old), weighing between 20–25 g,
from Central Bioterium of Butantan Institute, São Paulo,
Brazil. The animals were sacrificed in accordance with the
standards described in Use of Experimental Animals at
Johns Hopkins - Guide to the Care and Use of Experimen-
tal Animals.
Isolation and culture of ADSCs
In sterile conditions, under laminar flow, the abdominal
cavity was exposed and adipose tissue was isolated from
regions close to the ovarian infundibulum in females
and in the lateral epididymis region in males. The tissue
was mechanically separated and the material was proc-
essed under laminar flow also in such a way as to be
eliminated adipose tissue subjacent, leaving the dermo-
adipocyte sheet impregnated in Hank’s Balanced Salt
Solution (HBSS) (Gibco, Carlsbad, CA, United States).
The small fragments on a Petri plate of 35 mm were
incubated with type IV collagenase 0.2 U/ml for 3 h at
37°C in 5% CO2. Then, the collagenase was neutralized
with 10 ml of fetal bovine serum (Sigma-Aldrich, St. Louis,
MO, United States), the cellular debris were removed and
remaining material, consisting of vascular cells, fibroblasts
and adipocytes was solubilized in HBSS and filtered
through a 40 μm membrane. The concentrate obtained
from the previous step was centrifuged for 10 minutes at
274 × g and at 4°C, the supernatant formed was aspirated,
the cell pellet resuspended in 1 ml of complete culture
medium and cell culture flats were incubated containing
the material. After growth and expansion, to subconfluence,
the cells were resuspended in culture medium, trypsinized
and filtered. The filtrate was collected on cell culture flasks
containing 50 ml of saline solution supplemented with anti-
biotics. Finally, cells were quantified on Malassez chamber,
the concentration adjusted to 2 × 105 ml and plated for
different analyzes. ADSCs above three passages on tissue
culture plastic (P3) were analyzed for surface marker
expression.
Characterization of ADSCs by flow cytometry
After three passage ADSCs were detached using trypsin-
EDTA 0.2% (Gibco, Carlsbad, CA, United States) and
were counted. Then, 3% rat serum was added to aliquots
of about 2 × 105 cells in centrifuge tubes. The cells were
incubated on ice for 30 min, resuspended in PBS and
pelleted by centrifugation for 10 min at 274 × g. Then, the
cells were stained with CD105 (AbD Serotec, Raleigh, NC,
United States), CD45 (Sigma-Aldrich, St. Louis, MO,
United States), CD90 (Abcam, Cambridge, MA, United
States), CD34 (Santa Cruz Biotechnology, Dallas,
TX, United States), CD106 (Becton Dickinson, San
Jose, CA, United States), VEGFR-1 (Sigma-Aldrich, St.
Louis, MO, United States), Nanog (Abcam, Cambridge,
MA, United States) and SSEA-1 (Abcam, Cambridge, MA,
United States) at a concentration of 1 μg/ml at 4°C for
30 min. The corresponding isotope antibody was used as
negative control and as a secondary antibody was used
Goat anti Mouse IgG (H/L): FITC (AbD Serotec, Raleigh,
NC, United States). The cells were pelleted, washed twice
with PBS and fixed with 1% paraformaldehyde. Then,
fluorescence-activated cell sorting (FACS) analysis was per-
formed on BD Biosciences FacsCalibur flow cytometer
(Becton Dickinson, San Jose, CA, United States) using Cell
Quest, and Win MDI 2.9 softwares was used to acquisition
and histograms analysis. The small and large cells were
identified by forward (FSC) and side-angle light scatter
(SSC) characteristic by flow cytometry. Autofluorescence
was assessed by acquiring cells on the flow cytometry with-
out incubating with fluorochrome - labeled antibodies. Sur-
face antigen expression was determined with a variety of
directly labeled antibodies according to the supplier’s
recommendations.
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Determination of caspase-3 active and cyclin D1 by flow
cytometry
The cellular pellet was resuspended in phosphate-
buffered solution (PBS) at a concentration 5 × 105 cells/
mL and incubated for 1 h at 4°C with 1 μl of specific
antibodies: cyclin D1 conjugated with fluorescein iso-
thiocyanate (Abcam, Cambridge, MA, United States)
and specific antibody caspase-3 active with phycoeryth-
rin (PE) (Abcam, Cambridge, MA, United States), in
absence or presence of an Ac-Asp-Glu-Val-Asp-OH-
specific inhibitor (Abcam, Cambridge, MA, United
States). After this period the cells were centrifugate at
428 × g for 10 min, washed twice with PBS-cold and
fixed with 1% paraformaldehyde. Flow cytometer set-
tings were established using unstaining cells. Cells were
gated by forward scatter to eliminated debris. To elim-
inate the possible autofluorescence of ADSCs, the con-
tribution of unstained cells in the measurement channel
was removed. A minimum of 10,000 events was counted
for each analysis. Cells were evaluated for cell surface
proteins expression using BD Biosciences FacsCalibur
flow cytometer (Becton Dickinson, San Jose, CA, United
States) using Cell Quest, and Win MDI 2.9 softwares
was used to create the histograms.
Cell cycle phases analysis
The cells were washed with PBS and resuspended in 300 μl
0.03 g/l trypsin, 10 mM Tris (pH 8.0). After 15 min incuba-
tion at room temperature, 100ul of the neutralization solu-
tion (0.5 g/l trypsin inhibitor, 0.1 g/l RNase A and 1.2 g/l
spermine) was added and incubation continued for 15 min.
After centrifugation cells were resuspended in 300 μl PBS
and fixed by the addition of ice-cold ethanol 70%. Prior to
analysis, cells were incubated with 1.8 μg/ml propidium
iodide solution (Sigma-Aldrich, St. Louis, MO, United
States) and incubated in the dark for 30 min. Flow cytomet-
ric analysis was performed using a BD Biosciences FacsCali-
bur flow cytometer (Becton Dickinson, San Jose, CA,
United States) . The DNA content in the cell cycle phases
(sub-haploid, G0/G1, S and G2/M) was analyzed by the
Cell- Quest software and by the ModFit LT 3.2 software
(Becton Dickinson, San Jose, CA, United States).
Statistical analysis
Numerical values were expressed as mean ± standard devi-
ation. One-way analysis of variance (ANOVA) and Tukey-
Kramer multiple-comparisons test were performed to
identify differences among measurements of the groups
studied and the graphics were obtained by Prism version
5.0 and ModFit version 3.2 softwares. Statistical Signifi-
cance (p-value) *p < 0.05, **p < 0.01 and ***p < 0.001.
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